The PROVENT study, a multicentre double blind placebo controlled randomised trial to evaluate the effects of vitamin D and aspirin on progression of low risk prostate cancer during active surveillance
| dc.contributor.author | Shaw, G | en_US |
| dc.contributor.author | Oliver, T | en_US |
| dc.contributor.author | Kealy, R | en_US |
| dc.contributor.author | Powles, T | en_US |
| dc.contributor.author | Hillman, P | en_US |
| dc.contributor.author | Cuzick, J | en_US |
| dc.date.accessioned | 2021-10-28T09:28:09Z | |
| dc.date.available | 2021-10-28T09:28:09Z | |
| dc.date.issued | 2017-11-01 | en_US |
| dc.identifier.issn | 0748-7983 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/74794 | |
| dc.format.extent | 2212 - 2213 | en_US |
| dc.relation.ispartof | European Journal of Surgical Oncology | en_US |
| dc.title | The PROVENT study, a multicentre double blind placebo controlled randomised trial to evaluate the effects of vitamin D and aspirin on progression of low risk prostate cancer during active surveillance | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1016/j.ejso.2017.10.126 | en_US |
| pubs.issue | 11 | en_US |
| pubs.notes | Not known | en_US |
| pubs.volume | 43 | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1179]
